• Home
  • About
  • Blog
    • Testosterone & Anti-Aging Therapy
    • Sterile & Non-Sterile Compounding
    • Clinical Laboratory Analysis
    • Dietary Supplements & Nutraceuticals
    • Consulting Services
    • Anti-Aging News
  • Contact
Tirzepatide may not be removed from the FDA drug shortage list after all.

Tirzepatide may not be removed from the FDA drug shortage list after all.

by Anderson Triggs | Oct 13, 2024 | Anti-Aging News, Sterile & Non-Sterile Compounding

This week the pharmacy compounding, weight loss and anti-aging communities have been abuzz from the October 2, 2024 announcement from the FDA and Eli Lilly that they are removing both of the brand name tirzepatide blockbuster drugs, Mounjaro® and Zepbound® from the...
Anderson Triggs

Anderson Triggs

by admin | Oct 11, 2024 | Anti-Aging News, Clinical Laboratory Analysis, Consulting Services, Dietary Supplements & Nutraceuticals, Sterile & Non-Sterile Compounding, Testosterone & Anti-Aging Therapy

Curriculum Vitae The Professional Resume of Anderson Triggs The Education of Anderson L Triggs Masters in Business Administration, with Honors, May 2010, Nova Southeastern University, Davie, FL. Elected to Sigma Beta Delta Business Honorary Bachelor in Business...
Next Entries »

Recent Posts

  • Injectable BPC-157 vs. Pentadecapeptide Arginate
  • Testosterone Optimization Therapy (TOT) and Fertility Can Coexist
  • FDA’s Shift on Testosterone: A Long-Awaited Reversal
  • Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
  • Novo Nordisk asks the FDA to add Semaglutide to the Demonstrably Difficult to Compound list.

Check it Out

Check back in for upcoming promotions!

View Blog

Stay Tuned for updates and the latest news.

Sign Me Up
Track with Me
  • Home
  • About
  • Blog
    • Testosterone & Anti-Aging Therapy
    • Sterile & Non-Sterile Compounding
    • Clinical Laboratory Analysis
    • Dietary Supplements & Nutraceuticals
    • Consulting Services
    • Anti-Aging News
  • Contact

Success!

Subscribe

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
© 2026 Anderson Triggs | All Rights Reserved